nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—SELE—systemic lupus erythematosus	0.363	0.756	CbGaD
Carvedilol—VEGFA—systemic lupus erythematosus	0.117	0.244	CbGaD
Carvedilol—XDH—Azathioprine—systemic lupus erythematosus	0.0729	0.282	CbGbCtD
Carvedilol—PTGS1—Dapsone—systemic lupus erythematosus	0.02	0.0774	CbGbCtD
Carvedilol—CYP2E1—Dapsone—systemic lupus erythematosus	0.0154	0.0598	CbGbCtD
Carvedilol—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0125	0.0485	CbGbCtD
Carvedilol—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0113	0.0437	CbGbCtD
Carvedilol—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.00893	0.0346	CbGbCtD
Carvedilol—CYP1A1—Dexamethasone—systemic lupus erythematosus	0.00865	0.0335	CbGbCtD
Carvedilol—CYP2C9—Dapsone—systemic lupus erythematosus	0.00804	0.0311	CbGbCtD
Carvedilol—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00677	0.0262	CbGbCtD
Carvedilol—CYP2E1—Dexamethasone—systemic lupus erythematosus	0.00668	0.0259	CbGbCtD
Carvedilol—ABCB1—Betamethasone—systemic lupus erythematosus	0.00581	0.0225	CbGbCtD
Carvedilol—VCAM1—tunica intima—systemic lupus erythematosus	0.00576	0.0773	CbGeAlD
Carvedilol—ABCB1—Prednisolone—systemic lupus erythematosus	0.00573	0.0222	CbGbCtD
Carvedilol—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00543	0.021	CbGbCtD
Carvedilol—ABCB1—Prednisone—systemic lupus erythematosus	0.00541	0.021	CbGbCtD
Carvedilol—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00535	0.0207	CbGbCtD
Carvedilol—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00529	0.0205	CbGbCtD
Carvedilol—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00513	0.0199	CbGbCtD
Carvedilol—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.00483	0.0187	CbGbCtD
Carvedilol—CYP3A4—Dapsone—systemic lupus erythematosus	0.00468	0.0181	CbGbCtD
Carvedilol—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00406	0.0157	CbGbCtD
Carvedilol—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00406	0.0157	CbGbCtD
Carvedilol—SELE—umbilical vein—systemic lupus erythematosus	0.00382	0.0512	CbGeAlD
Carvedilol—VCAM1—umbilical vein—systemic lupus erythematosus	0.00351	0.0471	CbGeAlD
Carvedilol—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00348	0.0135	CbGbCtD
Carvedilol—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00348	0.0135	CbGbCtD
Carvedilol—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00343	0.0133	CbGbCtD
Carvedilol—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00338	0.0131	CbGbCtD
Carvedilol—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00325	0.0126	CbGbCtD
Carvedilol—CYP3A4—Prednisone—systemic lupus erythematosus	0.00324	0.0126	CbGbCtD
Carvedilol—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00318	0.0123	CbGbCtD
Carvedilol—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00307	0.0119	CbGbCtD
Carvedilol—CYP2C9—cardial valve—systemic lupus erythematosus	0.00285	0.0383	CbGeAlD
Carvedilol—ABCB1—Methotrexate—systemic lupus erythematosus	0.00271	0.0105	CbGbCtD
Carvedilol—NPPB—blood plasma—systemic lupus erythematosus	0.00238	0.0319	CbGeAlD
Carvedilol—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00202	0.00784	CbGbCtD
Carvedilol—SELE—endothelium—systemic lupus erythematosus	0.00181	0.0243	CbGeAlD
Carvedilol—VCAM1—endothelium—systemic lupus erythematosus	0.00166	0.0223	CbGeAlD
Carvedilol—SELE—blood plasma—systemic lupus erythematosus	0.00161	0.0216	CbGeAlD
Carvedilol—HIF1A—endothelium—systemic lupus erythematosus	0.0016	0.0215	CbGeAlD
Carvedilol—GJA1—endothelium—systemic lupus erythematosus	0.00155	0.0209	CbGeAlD
Carvedilol—VCAM1—blood plasma—systemic lupus erythematosus	0.00148	0.0198	CbGeAlD
Carvedilol—NPPB—lymphoid tissue—systemic lupus erythematosus	0.000926	0.0124	CbGeAlD
Carvedilol—SELE—connective tissue—systemic lupus erythematosus	0.000855	0.0115	CbGeAlD
Carvedilol—SELE—nephron tubule—systemic lupus erythematosus	0.000829	0.0111	CbGeAlD
Carvedilol—VCAM1—connective tissue—systemic lupus erythematosus	0.000787	0.0106	CbGeAlD
Carvedilol—SELE—skin of body—systemic lupus erythematosus	0.000772	0.0104	CbGeAlD
Carvedilol—VCAM1—nephron tubule—systemic lupus erythematosus	0.000762	0.0102	CbGeAlD
Carvedilol—HIF1A—connective tissue—systemic lupus erythematosus	0.000757	0.0102	CbGeAlD
Carvedilol—GJA1—connective tissue—systemic lupus erythematosus	0.000734	0.00986	CbGeAlD
Carvedilol—HIF1A—nephron tubule—systemic lupus erythematosus	0.000733	0.00985	CbGeAlD
Carvedilol—GJA1—nephron tubule—systemic lupus erythematosus	0.000711	0.00955	CbGeAlD
Carvedilol—SELE—cortex of kidney—systemic lupus erythematosus	0.000709	0.00952	CbGeAlD
Carvedilol—NPPB—nervous system—systemic lupus erythematosus	0.000707	0.0095	CbGeAlD
Carvedilol—HIF1A—skin of body—systemic lupus erythematosus	0.000684	0.00918	CbGeAlD
Carvedilol—NPPB—central nervous system—systemic lupus erythematosus	0.000681	0.00914	CbGeAlD
Carvedilol—ADRB3—connective tissue—systemic lupus erythematosus	0.000673	0.00904	CbGeAlD
Carvedilol—VCAM1—kidney—systemic lupus erythematosus	0.00067	0.00899	CbGeAlD
Carvedilol—GJA1—skin of body—systemic lupus erythematosus	0.000663	0.0089	CbGeAlD
Carvedilol—VCAM1—cortex of kidney—systemic lupus erythematosus	0.000652	0.00876	CbGeAlD
Carvedilol—CYP1A2—urine—systemic lupus erythematosus	0.000648	0.00869	CbGeAlD
Carvedilol—HIF1A—kidney—systemic lupus erythematosus	0.000645	0.00865	CbGeAlD
Carvedilol—HIF1A—cortex of kidney—systemic lupus erythematosus	0.000628	0.00843	CbGeAlD
Carvedilol—SELE—lymphoid tissue—systemic lupus erythematosus	0.000626	0.0084	CbGeAlD
Carvedilol—GJA1—kidney—systemic lupus erythematosus	0.000625	0.00839	CbGeAlD
Carvedilol—CYP2C9—urine—systemic lupus erythematosus	0.000615	0.00825	CbGeAlD
Carvedilol—GJA1—cortex of kidney—systemic lupus erythematosus	0.000609	0.00818	CbGeAlD
Carvedilol—SELE—tendon—systemic lupus erythematosus	0.000588	0.00789	CbGeAlD
Carvedilol—CYP2E1—urine—systemic lupus erythematosus	0.000583	0.00782	CbGeAlD
Carvedilol—VCAM1—lymphoid tissue—systemic lupus erythematosus	0.000575	0.00773	CbGeAlD
Carvedilol—VEGFA—nephron tubule—systemic lupus erythematosus	0.000562	0.00754	CbGeAlD
Carvedilol—HIF1A—lymphoid tissue—systemic lupus erythematosus	0.000554	0.00743	CbGeAlD
Carvedilol—NDUFC2—kidney—systemic lupus erythematosus	0.000544	0.00731	CbGeAlD
Carvedilol—VCAM1—tendon—systemic lupus erythematosus	0.000541	0.00726	CbGeAlD
Carvedilol—GJA1—lymphoid tissue—systemic lupus erythematosus	0.000537	0.00721	CbGeAlD
Carvedilol—NDUFC2—cortex of kidney—systemic lupus erythematosus	0.00053	0.00712	CbGeAlD
Carvedilol—VCAM1—bone marrow—systemic lupus erythematosus	0.000524	0.00703	CbGeAlD
Carvedilol—HIF1A—tendon—systemic lupus erythematosus	0.00052	0.00699	CbGeAlD
Carvedilol—SELE—lung—systemic lupus erythematosus	0.000516	0.00693	CbGeAlD
Carvedilol—GJA1—tendon—systemic lupus erythematosus	0.000505	0.00678	CbGeAlD
Carvedilol—HIF1A—bone marrow—systemic lupus erythematosus	0.000504	0.00677	CbGeAlD
Carvedilol—GJA1—bone marrow—systemic lupus erythematosus	0.000489	0.00657	CbGeAlD
Carvedilol—VEGFA—cortex of kidney—systemic lupus erythematosus	0.000481	0.00646	CbGeAlD
Carvedilol—SELE—nervous system—systemic lupus erythematosus	0.000478	0.00642	CbGeAlD
Carvedilol—VCAM1—lung—systemic lupus erythematosus	0.000475	0.00637	CbGeAlD
Carvedilol—CYP3A4—urine—systemic lupus erythematosus	0.000469	0.00629	CbGeAlD
Carvedilol—NDUFC2—lymphoid tissue—systemic lupus erythematosus	0.000467	0.00628	CbGeAlD
Carvedilol—CYP2D6—urine—systemic lupus erythematosus	0.000461	0.00619	CbGeAlD
Carvedilol—SELE—central nervous system—systemic lupus erythematosus	0.00046	0.00618	CbGeAlD
Carvedilol—HIF1A—lung—systemic lupus erythematosus	0.000457	0.00613	CbGeAlD
Carvedilol—GJA1—lung—systemic lupus erythematosus	0.000443	0.00595	CbGeAlD
Carvedilol—VCAM1—nervous system—systemic lupus erythematosus	0.00044	0.0059	CbGeAlD
Carvedilol—XDH—kidney—systemic lupus erythematosus	0.000439	0.0059	CbGeAlD
Carvedilol—NDUFC2—tendon—systemic lupus erythematosus	0.000439	0.0059	CbGeAlD
Carvedilol—NDUFC2—bone marrow—systemic lupus erythematosus	0.000426	0.00571	CbGeAlD
Carvedilol—VCAM1—central nervous system—systemic lupus erythematosus	0.000423	0.00568	CbGeAlD
Carvedilol—HIF1A—nervous system—systemic lupus erythematosus	0.000423	0.00568	CbGeAlD
Carvedilol—GJA1—nervous system—systemic lupus erythematosus	0.00041	0.00551	CbGeAlD
Carvedilol—HIF1A—central nervous system—systemic lupus erythematosus	0.000407	0.00547	CbGeAlD
Carvedilol—VEGFA—tendon—systemic lupus erythematosus	0.000399	0.00535	CbGeAlD
Carvedilol—GJA1—central nervous system—systemic lupus erythematosus	0.000395	0.0053	CbGeAlD
Carvedilol—VEGFA—bone marrow—systemic lupus erythematosus	0.000386	0.00518	CbGeAlD
Carvedilol—NDUFC2—lung—systemic lupus erythematosus	0.000386	0.00518	CbGeAlD
Carvedilol—NDUFC2—nervous system—systemic lupus erythematosus	0.000357	0.00479	CbGeAlD
Carvedilol—VEGFA—lung—systemic lupus erythematosus	0.00035	0.0047	CbGeAlD
Carvedilol—NDUFC2—central nervous system—systemic lupus erythematosus	0.000344	0.00462	CbGeAlD
Carvedilol—CYP1A2—blood plasma—systemic lupus erythematosus	0.000338	0.00454	CbGeAlD
Carvedilol—PTGS1—endothelium—systemic lupus erythematosus	0.00033	0.00443	CbGeAlD
Carvedilol—ADRA1B—kidney—systemic lupus erythematosus	0.00033	0.00443	CbGeAlD
Carvedilol—CYP2C9—blood plasma—systemic lupus erythematosus	0.000321	0.00431	CbGeAlD
Carvedilol—ADRA2A—blood plasma—systemic lupus erythematosus	0.000311	0.00417	CbGeAlD
Carvedilol—CYP2E1—blood plasma—systemic lupus erythematosus	0.000304	0.00408	CbGeAlD
Carvedilol—PTGS1—blood plasma—systemic lupus erythematosus	0.000293	0.00393	CbGeAlD
Carvedilol—ADRB1—connective tissue—systemic lupus erythematosus	0.000275	0.00369	CbGeAlD
Carvedilol—GJA1—Cortisone acetate—Hydrocortisone—systemic lupus erythematosus	0.000245	0.0833	CbGdCrCtD
Carvedilol—CYP3A4—blood plasma—systemic lupus erythematosus	0.000245	0.00328	CbGeAlD
Carvedilol—CYP2D6—blood plasma—systemic lupus erythematosus	0.000241	0.00323	CbGeAlD
Carvedilol—GJA1—Cortisone acetate—Methylprednisolone—systemic lupus erythematosus	0.000231	0.0786	CbGdCrCtD
Carvedilol—ADRA1B—nervous system—systemic lupus erythematosus	0.000216	0.0029	CbGeAlD
Carvedilol—ADRA1D—nervous system—systemic lupus erythematosus	0.000212	0.00284	CbGeAlD
Carvedilol—GJA1—Cortisone acetate—Prednisone—systemic lupus erythematosus	0.000211	0.0717	CbGdCrCtD
Carvedilol—ADRA1B—central nervous system—systemic lupus erythematosus	0.000208	0.0028	CbGeAlD
Carvedilol—GJA1—Cortisone acetate—Prednisolone—systemic lupus erythematosus	0.000206	0.07	CbGdCrCtD
Carvedilol—ADRA1D—central nervous system—systemic lupus erythematosus	0.000204	0.00274	CbGeAlD
Carvedilol—ADRA2C—nephron tubule—systemic lupus erythematosus	0.000201	0.0027	CbGeAlD
Carvedilol—ADRA2C—kidney—systemic lupus erythematosus	0.000177	0.00237	CbGeAlD
Carvedilol—ABCB1—blood plasma—systemic lupus erythematosus	0.000173	0.00232	CbGeAlD
Carvedilol—ADRA2C—cortex of kidney—systemic lupus erythematosus	0.000172	0.00231	CbGeAlD
Carvedilol—ADRB1—lung—systemic lupus erythematosus	0.000166	0.00223	CbGeAlD
Carvedilol—ADRA2A—connective tissue—systemic lupus erythematosus	0.000165	0.00222	CbGeAlD
Carvedilol—GJA1—Rimexolone—Hydrocortisone—systemic lupus erythematosus	0.000165	0.0561	CbGdCrCtD
Carvedilol—CYP1A1—skin of body—systemic lupus erythematosus	0.00016	0.00215	CbGeAlD
Carvedilol—ADRA1A—lymphoid tissue—systemic lupus erythematosus	0.000159	0.00214	CbGeAlD
Carvedilol—CYP2E1—nephron tubule—systemic lupus erythematosus	0.000157	0.00211	CbGeAlD
Carvedilol—PTGS1—connective tissue—systemic lupus erythematosus	0.000156	0.00209	CbGeAlD
Carvedilol—GJA1—Rimexolone—Methylprednisolone—systemic lupus erythematosus	0.000156	0.0529	CbGdCrCtD
Carvedilol—ADRB1—nervous system—systemic lupus erythematosus	0.000154	0.00206	CbGeAlD
Carvedilol—GJA1—Rimexolone—Betamethasone—systemic lupus erythematosus	0.000153	0.0521	CbGdCrCtD
Carvedilol—GJA1—Rimexolone—Dexamethasone—systemic lupus erythematosus	0.000153	0.0521	CbGdCrCtD
Carvedilol—CYP1A1—kidney—systemic lupus erythematosus	0.000151	0.00203	CbGeAlD
Carvedilol—GJA1—Rimexolone—Triamcinolone—systemic lupus erythematosus	0.00015	0.0509	CbGdCrCtD
Carvedilol—ADRB1—central nervous system—systemic lupus erythematosus	0.000148	0.00199	CbGeAlD
Carvedilol—ADRA2C—tendon—systemic lupus erythematosus	0.000143	0.00191	CbGeAlD
Carvedilol—GJA1—Rimexolone—Prednisone—systemic lupus erythematosus	0.000142	0.0483	CbGdCrCtD
Carvedilol—PTGS1—skin of body—systemic lupus erythematosus	0.000141	0.00189	CbGeAlD
Carvedilol—KCNH2—bone marrow—systemic lupus erythematosus	0.00014	0.00188	CbGeAlD
Carvedilol—GJA1—Rimexolone—Prednisolone—systemic lupus erythematosus	0.000139	0.0471	CbGdCrCtD
Carvedilol—CYP2E1—kidney—systemic lupus erythematosus	0.000138	0.00185	CbGeAlD
Carvedilol—ADRA2A—cortex of kidney—systemic lupus erythematosus	0.000137	0.00184	CbGeAlD
Carvedilol—CYP2E1—cortex of kidney—systemic lupus erythematosus	0.000134	0.0018	CbGeAlD
Carvedilol—PTGS1—kidney—systemic lupus erythematosus	0.000133	0.00178	CbGeAlD
Carvedilol—ADRA2C—lung—systemic lupus erythematosus	0.000125	0.00168	CbGeAlD
Carvedilol—ADRA1A—nervous system—systemic lupus erythematosus	0.000122	0.00163	CbGeAlD
Carvedilol—GJA1—Progesterone—Hydrocortisone—systemic lupus erythematosus	0.00012	0.0408	CbGdCrCtD
Carvedilol—CYP2E1—lymphoid tissue—systemic lupus erythematosus	0.000118	0.00159	CbGeAlD
Carvedilol—KCNH2—nervous system—systemic lupus erythematosus	0.000117	0.00158	CbGeAlD
Carvedilol—ADRA1A—central nervous system—systemic lupus erythematosus	0.000117	0.00157	CbGeAlD
Carvedilol—ADRA2C—nervous system—systemic lupus erythematosus	0.000116	0.00156	CbGeAlD
Carvedilol—ADRA2A—tendon—systemic lupus erythematosus	0.000114	0.00153	CbGeAlD
Carvedilol—KCNH2—central nervous system—systemic lupus erythematosus	0.000113	0.00152	CbGeAlD
Carvedilol—ADRA2C—central nervous system—systemic lupus erythematosus	0.000112	0.0015	CbGeAlD
Carvedilol—CYP2E1—tendon—systemic lupus erythematosus	0.000111	0.00149	CbGeAlD
Carvedilol—CYP3A4—kidney—systemic lupus erythematosus	0.000111	0.00149	CbGeAlD
Carvedilol—CYP2D6—kidney—systemic lupus erythematosus	0.000109	0.00146	CbGeAlD
Carvedilol—CYP1A2—lung—systemic lupus erythematosus	0.000109	0.00146	CbGeAlD
Carvedilol—PTGS1—tendon—systemic lupus erythematosus	0.000107	0.00144	CbGeAlD
Carvedilol—CYP1A1—lung—systemic lupus erythematosus	0.000107	0.00144	CbGeAlD
Carvedilol—GJA1—Progesterone—Prednisolone—systemic lupus erythematosus	0.000101	0.0343	CbGdCrCtD
Carvedilol—ADRA2A—lung—systemic lupus erythematosus	9.98e-05	0.00134	CbGeAlD
Carvedilol—CYP1A1—nervous system—systemic lupus erythematosus	9.91e-05	0.00133	CbGeAlD
Carvedilol—CYP2E1—lung—systemic lupus erythematosus	9.76e-05	0.00131	CbGeAlD
Carvedilol—CYP1A1—central nervous system—systemic lupus erythematosus	9.55e-05	0.00128	CbGeAlD
Carvedilol—PTGS1—lung—systemic lupus erythematosus	9.41e-05	0.00126	CbGeAlD
Carvedilol—ADRA2A—nervous system—systemic lupus erythematosus	9.24e-05	0.00124	CbGeAlD
Carvedilol—CYP2E1—nervous system—systemic lupus erythematosus	9.04e-05	0.00121	CbGeAlD
Carvedilol—ABCB1—nephron tubule—systemic lupus erythematosus	8.93e-05	0.0012	CbGeAlD
Carvedilol—ADRA2A—central nervous system—systemic lupus erythematosus	8.9e-05	0.00119	CbGeAlD
Carvedilol—PTGS1—nervous system—systemic lupus erythematosus	8.71e-05	0.00117	CbGeAlD
Carvedilol—CYP2E1—central nervous system—systemic lupus erythematosus	8.71e-05	0.00117	CbGeAlD
Carvedilol—PTGS1—central nervous system—systemic lupus erythematosus	8.39e-05	0.00113	CbGeAlD
Carvedilol—ABCB1—kidney—systemic lupus erythematosus	7.85e-05	0.00105	CbGeAlD
Carvedilol—ABCB1—cortex of kidney—systemic lupus erythematosus	7.64e-05	0.00103	CbGeAlD
Carvedilol—CYP3A4—nervous system—systemic lupus erythematosus	7.28e-05	0.000977	CbGeAlD
Carvedilol—CYP2D6—nervous system—systemic lupus erythematosus	7.16e-05	0.000961	CbGeAlD
Carvedilol—CYP3A4—central nervous system—systemic lupus erythematosus	7e-05	0.00094	CbGeAlD
Carvedilol—CYP2D6—central nervous system—systemic lupus erythematosus	6.89e-05	0.000925	CbGeAlD
Carvedilol—ABCB1—lymphoid tissue—systemic lupus erythematosus	6.74e-05	0.000905	CbGeAlD
Carvedilol—ABCB1—bone marrow—systemic lupus erythematosus	6.14e-05	0.000824	CbGeAlD
Carvedilol—ABCB1—lung—systemic lupus erythematosus	5.56e-05	0.000747	CbGeAlD
Carvedilol—ABCB1—nervous system—systemic lupus erythematosus	5.15e-05	0.000691	CbGeAlD
Carvedilol—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	5.03e-05	0.000493	CcSEcCtD
Carvedilol—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	5.03e-05	0.000493	CcSEcCtD
Carvedilol—Nausea—Leflunomide—systemic lupus erythematosus	5.02e-05	0.000493	CcSEcCtD
Carvedilol—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	5.01e-05	0.000492	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	5.01e-05	0.000491	CcSEcCtD
Carvedilol—Fatigue—Hydrocortisone—systemic lupus erythematosus	5e-05	0.00049	CcSEcCtD
Carvedilol—Vision blurred—Prednisone—systemic lupus erythematosus	4.98e-05	0.000489	CcSEcCtD
Carvedilol—Urethral disorder—Methotrexate—systemic lupus erythematosus	4.97e-05	0.000488	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	4.97e-05	0.000488	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	4.96e-05	0.000487	CcSEcCtD
Carvedilol—Pain—Hydrocortisone—systemic lupus erythematosus	4.96e-05	0.000486	CcSEcCtD
Carvedilol—ABCB1—central nervous system—systemic lupus erythematosus	4.96e-05	0.000666	CbGeAlD
Carvedilol—Oedema—Dexamethasone—systemic lupus erythematosus	4.95e-05	0.000486	CcSEcCtD
Carvedilol—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	4.95e-05	0.000486	CcSEcCtD
Carvedilol—Oedema—Betamethasone—systemic lupus erythematosus	4.95e-05	0.000486	CcSEcCtD
Carvedilol—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	4.95e-05	0.000486	CcSEcCtD
Carvedilol—Insomnia—Triamcinolone—systemic lupus erythematosus	4.94e-05	0.000484	CcSEcCtD
Carvedilol—Insomnia—Methylprednisolone—systemic lupus erythematosus	4.93e-05	0.000483	CcSEcCtD
Carvedilol—Infection—Dexamethasone—systemic lupus erythematosus	4.92e-05	0.000483	CcSEcCtD
Carvedilol—Infection—Betamethasone—systemic lupus erythematosus	4.92e-05	0.000483	CcSEcCtD
Carvedilol—Ill-defined disorder—Prednisone—systemic lupus erythematosus	4.9e-05	0.000481	CcSEcCtD
Carvedilol—Paraesthesia—Triamcinolone—systemic lupus erythematosus	4.9e-05	0.000481	CcSEcCtD
Carvedilol—Feeling abnormal—Prednisolone—systemic lupus erythematosus	4.89e-05	0.00048	CcSEcCtD
Carvedilol—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	4.89e-05	0.00048	CcSEcCtD
Carvedilol—Visual impairment—Methotrexate—systemic lupus erythematosus	4.89e-05	0.00048	CcSEcCtD
Carvedilol—Anaemia—Prednisone—systemic lupus erythematosus	4.89e-05	0.000479	CcSEcCtD
Carvedilol—Shock—Dexamethasone—systemic lupus erythematosus	4.87e-05	0.000478	CcSEcCtD
Carvedilol—Shock—Betamethasone—systemic lupus erythematosus	4.87e-05	0.000478	CcSEcCtD
Carvedilol—Dyspnoea—Triamcinolone—systemic lupus erythematosus	4.87e-05	0.000477	CcSEcCtD
Carvedilol—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	4.85e-05	0.000476	CcSEcCtD
Carvedilol—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	4.85e-05	0.000476	CcSEcCtD
Carvedilol—Tachycardia—Betamethasone—systemic lupus erythematosus	4.83e-05	0.000474	CcSEcCtD
Carvedilol—Tachycardia—Dexamethasone—systemic lupus erythematosus	4.83e-05	0.000474	CcSEcCtD
Carvedilol—Angioedema—Prednisone—systemic lupus erythematosus	4.83e-05	0.000474	CcSEcCtD
Carvedilol—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	4.81e-05	0.000471	CcSEcCtD
Carvedilol—Dyspepsia—Triamcinolone—systemic lupus erythematosus	4.81e-05	0.000471	CcSEcCtD
Carvedilol—Erythema multiforme—Methotrexate—systemic lupus erythematosus	4.8e-05	0.000471	CcSEcCtD
Carvedilol—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	4.8e-05	0.00047	CcSEcCtD
Carvedilol—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	4.79e-05	0.00047	CcSEcCtD
Carvedilol—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	4.79e-05	0.00047	CcSEcCtD
Carvedilol—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	4.78e-05	0.000469	CcSEcCtD
Carvedilol—Malaise—Prednisone—systemic lupus erythematosus	4.77e-05	0.000468	CcSEcCtD
Carvedilol—Vertigo—Prednisone—systemic lupus erythematosus	4.75e-05	0.000466	CcSEcCtD
Carvedilol—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	4.74e-05	0.000465	CcSEcCtD
Carvedilol—Syncope—Prednisone—systemic lupus erythematosus	4.74e-05	0.000465	CcSEcCtD
Carvedilol—Tinnitus—Methotrexate—systemic lupus erythematosus	4.73e-05	0.000464	CcSEcCtD
Carvedilol—Anorexia—Betamethasone—systemic lupus erythematosus	4.72e-05	0.000463	CcSEcCtD
Carvedilol—Anorexia—Dexamethasone—systemic lupus erythematosus	4.72e-05	0.000463	CcSEcCtD
Carvedilol—Urticaria—Prednisolone—systemic lupus erythematosus	4.72e-05	0.000463	CcSEcCtD
Carvedilol—Fatigue—Triamcinolone—systemic lupus erythematosus	4.71e-05	0.000462	CcSEcCtD
Carvedilol—Fatigue—Methylprednisolone—systemic lupus erythematosus	4.7e-05	0.000461	CcSEcCtD
Carvedilol—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	4.69e-05	0.00046	CcSEcCtD
Carvedilol—Asthenia—Cyclosporine—systemic lupus erythematosus	4.68e-05	0.000459	CcSEcCtD
Carvedilol—Pain—Triamcinolone—systemic lupus erythematosus	4.67e-05	0.000458	CcSEcCtD
Carvedilol—Loss of consciousness—Prednisone—systemic lupus erythematosus	4.65e-05	0.000456	CcSEcCtD
Carvedilol—Hypotension—Dexamethasone—systemic lupus erythematosus	4.63e-05	0.000454	CcSEcCtD
Carvedilol—Hypotension—Betamethasone—systemic lupus erythematosus	4.63e-05	0.000454	CcSEcCtD
Carvedilol—Pruritus—Cyclosporine—systemic lupus erythematosus	4.62e-05	0.000453	CcSEcCtD
Carvedilol—Urticaria—Hydrocortisone—systemic lupus erythematosus	4.61e-05	0.000452	CcSEcCtD
Carvedilol—Angiopathy—Methotrexate—systemic lupus erythematosus	4.6e-05	0.000452	CcSEcCtD
Carvedilol—Immune system disorder—Methotrexate—systemic lupus erythematosus	4.58e-05	0.00045	CcSEcCtD
Carvedilol—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	4.58e-05	0.00045	CcSEcCtD
Carvedilol—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	4.58e-05	0.00045	CcSEcCtD
Carvedilol—Convulsion—Prednisone—systemic lupus erythematosus	4.58e-05	0.000449	CcSEcCtD
Carvedilol—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	4.57e-05	0.000449	CcSEcCtD
Carvedilol—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	4.57e-05	0.000448	CcSEcCtD
Carvedilol—Hypertension—Prednisone—systemic lupus erythematosus	4.56e-05	0.000448	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	4.51e-05	0.000443	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	4.51e-05	0.000443	CcSEcCtD
Carvedilol—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	4.5e-05	0.000442	CcSEcCtD
Carvedilol—Myalgia—Prednisone—systemic lupus erythematosus	4.5e-05	0.000441	CcSEcCtD
Carvedilol—Arthralgia—Prednisone—systemic lupus erythematosus	4.5e-05	0.000441	CcSEcCtD
Carvedilol—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	4.5e-05	0.000441	CcSEcCtD
Carvedilol—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	4.49e-05	0.00044	CcSEcCtD
Carvedilol—Alopecia—Methotrexate—systemic lupus erythematosus	4.48e-05	0.00044	CcSEcCtD
Carvedilol—Insomnia—Betamethasone—systemic lupus erythematosus	4.48e-05	0.000439	CcSEcCtD
Carvedilol—Insomnia—Dexamethasone—systemic lupus erythematosus	4.48e-05	0.000439	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	4.47e-05	0.000438	CcSEcCtD
Carvedilol—Diarrhoea—Cyclosporine—systemic lupus erythematosus	4.46e-05	0.000438	CcSEcCtD
Carvedilol—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	4.45e-05	0.000437	CcSEcCtD
Carvedilol—Paraesthesia—Betamethasone—systemic lupus erythematosus	4.45e-05	0.000436	CcSEcCtD
Carvedilol—Paraesthesia—Dexamethasone—systemic lupus erythematosus	4.45e-05	0.000436	CcSEcCtD
Carvedilol—Discomfort—Prednisone—systemic lupus erythematosus	4.45e-05	0.000436	CcSEcCtD
Carvedilol—Malnutrition—Methotrexate—systemic lupus erythematosus	4.42e-05	0.000433	CcSEcCtD
Carvedilol—Hypersensitivity—Prednisolone—systemic lupus erythematosus	4.37e-05	0.000429	CcSEcCtD
Carvedilol—Dyspepsia—Betamethasone—systemic lupus erythematosus	4.36e-05	0.000428	CcSEcCtD
Carvedilol—Dyspepsia—Dexamethasone—systemic lupus erythematosus	4.36e-05	0.000428	CcSEcCtD
Carvedilol—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	4.35e-05	0.000427	CcSEcCtD
Carvedilol—Urticaria—Triamcinolone—systemic lupus erythematosus	4.34e-05	0.000425	CcSEcCtD
Carvedilol—Urticaria—Methylprednisolone—systemic lupus erythematosus	4.33e-05	0.000424	CcSEcCtD
Carvedilol—Body temperature increased—Triamcinolone—systemic lupus erythematosus	4.32e-05	0.000423	CcSEcCtD
Carvedilol—Dizziness—Cyclosporine—systemic lupus erythematosus	4.31e-05	0.000423	CcSEcCtD
Carvedilol—Oedema—Prednisone—systemic lupus erythematosus	4.31e-05	0.000423	CcSEcCtD
Carvedilol—Anaphylactic shock—Prednisone—systemic lupus erythematosus	4.31e-05	0.000423	CcSEcCtD
Carvedilol—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	4.31e-05	0.000422	CcSEcCtD
Carvedilol—Decreased appetite—Dexamethasone—systemic lupus erythematosus	4.31e-05	0.000422	CcSEcCtD
Carvedilol—Decreased appetite—Betamethasone—systemic lupus erythematosus	4.31e-05	0.000422	CcSEcCtD
Carvedilol—Infection—Prednisone—systemic lupus erythematosus	4.29e-05	0.00042	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	4.28e-05	0.000419	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	4.28e-05	0.000419	CcSEcCtD
Carvedilol—Back pain—Methotrexate—systemic lupus erythematosus	4.27e-05	0.000419	CcSEcCtD
Carvedilol—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	4.27e-05	0.000419	CcSEcCtD
Carvedilol—Fatigue—Dexamethasone—systemic lupus erythematosus	4.27e-05	0.000419	CcSEcCtD
Carvedilol—Fatigue—Betamethasone—systemic lupus erythematosus	4.27e-05	0.000419	CcSEcCtD
Carvedilol—Shock—Prednisone—systemic lupus erythematosus	4.24e-05	0.000416	CcSEcCtD
Carvedilol—Pain—Dexamethasone—systemic lupus erythematosus	4.24e-05	0.000415	CcSEcCtD
Carvedilol—Pain—Betamethasone—systemic lupus erythematosus	4.24e-05	0.000415	CcSEcCtD
Carvedilol—Tachycardia—Prednisone—systemic lupus erythematosus	4.21e-05	0.000413	CcSEcCtD
Carvedilol—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	4.21e-05	0.000413	CcSEcCtD
Carvedilol—Skin disorder—Prednisone—systemic lupus erythematosus	4.19e-05	0.000411	CcSEcCtD
Carvedilol—Hyperhidrosis—Prednisone—systemic lupus erythematosus	4.17e-05	0.000409	CcSEcCtD
Carvedilol—Vision blurred—Methotrexate—systemic lupus erythematosus	4.16e-05	0.000408	CcSEcCtD
Carvedilol—Asthenia—Hydrocortisone—systemic lupus erythematosus	4.16e-05	0.000408	CcSEcCtD
Carvedilol—Vomiting—Cyclosporine—systemic lupus erythematosus	4.15e-05	0.000407	CcSEcCtD
Carvedilol—Rash—Cyclosporine—systemic lupus erythematosus	4.11e-05	0.000403	CcSEcCtD
Carvedilol—Anorexia—Prednisone—systemic lupus erythematosus	4.11e-05	0.000403	CcSEcCtD
Carvedilol—Dermatitis—Cyclosporine—systemic lupus erythematosus	4.11e-05	0.000403	CcSEcCtD
Carvedilol—Pruritus—Hydrocortisone—systemic lupus erythematosus	4.1e-05	0.000402	CcSEcCtD
Carvedilol—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	4.1e-05	0.000402	CcSEcCtD
Carvedilol—Headache—Cyclosporine—systemic lupus erythematosus	4.09e-05	0.000401	CcSEcCtD
Carvedilol—Anaemia—Methotrexate—systemic lupus erythematosus	4.08e-05	0.0004	CcSEcCtD
Carvedilol—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	4.08e-05	0.0004	CcSEcCtD
Carvedilol—Feeling abnormal—Betamethasone—systemic lupus erythematosus	4.08e-05	0.0004	CcSEcCtD
Carvedilol—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	4.05e-05	0.000397	CcSEcCtD
Carvedilol—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	4.05e-05	0.000397	CcSEcCtD
Carvedilol—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	4.05e-05	0.000397	CcSEcCtD
Carvedilol—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	4.02e-05	0.000395	CcSEcCtD
Carvedilol—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	4.01e-05	0.000394	CcSEcCtD
Carvedilol—Rash—Mycophenolate mofetil—systemic lupus erythematosus	4.01e-05	0.000394	CcSEcCtD
Carvedilol—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	4.01e-05	0.000393	CcSEcCtD
Carvedilol—Headache—Mycophenolate mofetil—systemic lupus erythematosus	3.99e-05	0.000391	CcSEcCtD
Carvedilol—Malaise—Methotrexate—systemic lupus erythematosus	3.98e-05	0.000391	CcSEcCtD
Carvedilol—Vertigo—Methotrexate—systemic lupus erythematosus	3.97e-05	0.000389	CcSEcCtD
Carvedilol—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.97e-05	0.000389	CcSEcCtD
Carvedilol—Leukopenia—Methotrexate—systemic lupus erythematosus	3.95e-05	0.000388	CcSEcCtD
Carvedilol—Urticaria—Dexamethasone—systemic lupus erythematosus	3.94e-05	0.000386	CcSEcCtD
Carvedilol—Urticaria—Betamethasone—systemic lupus erythematosus	3.94e-05	0.000386	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	3.93e-05	0.000386	CcSEcCtD
Carvedilol—Dizziness—Prednisolone—systemic lupus erythematosus	3.93e-05	0.000385	CcSEcCtD
Carvedilol—Asthenia—Triamcinolone—systemic lupus erythematosus	3.92e-05	0.000384	CcSEcCtD
Carvedilol—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.92e-05	0.000384	CcSEcCtD
Carvedilol—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.92e-05	0.000384	CcSEcCtD
Carvedilol—Abdominal pain—Betamethasone—systemic lupus erythematosus	3.92e-05	0.000384	CcSEcCtD
Carvedilol—Abdominal pain—Dexamethasone—systemic lupus erythematosus	3.92e-05	0.000384	CcSEcCtD
Carvedilol—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.91e-05	0.000383	CcSEcCtD
Carvedilol—Insomnia—Prednisone—systemic lupus erythematosus	3.9e-05	0.000383	CcSEcCtD
Carvedilol—Nausea—Cyclosporine—systemic lupus erythematosus	3.88e-05	0.00038	CcSEcCtD
Carvedilol—Paraesthesia—Prednisone—systemic lupus erythematosus	3.87e-05	0.00038	CcSEcCtD
Carvedilol—Pruritus—Triamcinolone—systemic lupus erythematosus	3.86e-05	0.000379	CcSEcCtD
Carvedilol—Cough—Methotrexate—systemic lupus erythematosus	3.85e-05	0.000378	CcSEcCtD
Carvedilol—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.85e-05	0.000378	CcSEcCtD
Carvedilol—Dizziness—Hydrocortisone—systemic lupus erythematosus	3.83e-05	0.000376	CcSEcCtD
Carvedilol—Convulsion—Methotrexate—systemic lupus erythematosus	3.83e-05	0.000375	CcSEcCtD
Carvedilol—Dyspepsia—Prednisone—systemic lupus erythematosus	3.8e-05	0.000372	CcSEcCtD
Carvedilol—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3.78e-05	0.000371	CcSEcCtD
Carvedilol—Chest pain—Methotrexate—systemic lupus erythematosus	3.76e-05	0.000369	CcSEcCtD
Carvedilol—Myalgia—Methotrexate—systemic lupus erythematosus	3.76e-05	0.000369	CcSEcCtD
Carvedilol—Arthralgia—Methotrexate—systemic lupus erythematosus	3.76e-05	0.000369	CcSEcCtD
Carvedilol—Decreased appetite—Prednisone—systemic lupus erythematosus	3.75e-05	0.000368	CcSEcCtD
Carvedilol—Rash—Prednisolone—systemic lupus erythematosus	3.74e-05	0.000367	CcSEcCtD
Carvedilol—Dermatitis—Prednisolone—systemic lupus erythematosus	3.74e-05	0.000367	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.74e-05	0.000366	CcSEcCtD
Carvedilol—GJA1—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	3.73e-05	0.0127	CbGdCrCtD
Carvedilol—GJA1—Betamethasone—Hydrocortisone—systemic lupus erythematosus	3.73e-05	0.0127	CbGdCrCtD
Carvedilol—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.73e-05	0.000366	CcSEcCtD
Carvedilol—Fatigue—Prednisone—systemic lupus erythematosus	3.72e-05	0.000365	CcSEcCtD
Carvedilol—Headache—Prednisolone—systemic lupus erythematosus	3.72e-05	0.000365	CcSEcCtD
Carvedilol—Discomfort—Methotrexate—systemic lupus erythematosus	3.72e-05	0.000364	CcSEcCtD
Carvedilol—Constipation—Prednisone—systemic lupus erythematosus	3.69e-05	0.000362	CcSEcCtD
Carvedilol—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.69e-05	0.000362	CcSEcCtD
Carvedilol—Rash—Hydrocortisone—systemic lupus erythematosus	3.66e-05	0.000359	CcSEcCtD
Carvedilol—Dermatitis—Hydrocortisone—systemic lupus erythematosus	3.65e-05	0.000358	CcSEcCtD
Carvedilol—Confusional state—Methotrexate—systemic lupus erythematosus	3.64e-05	0.000357	CcSEcCtD
Carvedilol—Headache—Hydrocortisone—systemic lupus erythematosus	3.63e-05	0.000356	CcSEcCtD
Carvedilol—Dizziness—Triamcinolone—systemic lupus erythematosus	3.61e-05	0.000354	CcSEcCtD
Carvedilol—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	3.61e-05	0.000354	CcSEcCtD
Carvedilol—Dizziness—Methylprednisolone—systemic lupus erythematosus	3.6e-05	0.000353	CcSEcCtD
Carvedilol—Infection—Methotrexate—systemic lupus erythematosus	3.58e-05	0.000351	CcSEcCtD
Carvedilol—Feeling abnormal—Prednisone—systemic lupus erythematosus	3.55e-05	0.000349	CcSEcCtD
Carvedilol—Asthenia—Dexamethasone—systemic lupus erythematosus	3.55e-05	0.000349	CcSEcCtD
Carvedilol—Asthenia—Betamethasone—systemic lupus erythematosus	3.55e-05	0.000349	CcSEcCtD
Carvedilol—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	3.53e-05	0.000346	CcSEcCtD
Carvedilol—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	3.53e-05	0.000346	CcSEcCtD
Carvedilol—Nausea—Prednisolone—systemic lupus erythematosus	3.53e-05	0.000346	CcSEcCtD
Carvedilol—GJA1—Betamethasone—Methylprednisolone—systemic lupus erythematosus	3.52e-05	0.012	CbGdCrCtD
Carvedilol—GJA1—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	3.52e-05	0.012	CbGdCrCtD
Carvedilol—Pruritus—Betamethasone—systemic lupus erythematosus	3.5e-05	0.000344	CcSEcCtD
Carvedilol—Pruritus—Dexamethasone—systemic lupus erythematosus	3.5e-05	0.000344	CcSEcCtD
Carvedilol—Skin disorder—Methotrexate—systemic lupus erythematosus	3.5e-05	0.000343	CcSEcCtD
Carvedilol—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	3.49e-05	0.000342	CcSEcCtD
Carvedilol—Vomiting—Triamcinolone—systemic lupus erythematosus	3.47e-05	0.00034	CcSEcCtD
Carvedilol—GJA1—Betamethasone—Dexamethasone—systemic lupus erythematosus	3.47e-05	0.0118	CbGdCrCtD
Carvedilol—GJA1—Dexamethasone—Betamethasone—systemic lupus erythematosus	3.47e-05	0.0118	CbGdCrCtD
Carvedilol—Vomiting—Methylprednisolone—systemic lupus erythematosus	3.46e-05	0.00034	CcSEcCtD
Carvedilol—Nausea—Hydrocortisone—systemic lupus erythematosus	3.44e-05	0.000338	CcSEcCtD
Carvedilol—Rash—Triamcinolone—systemic lupus erythematosus	3.44e-05	0.000338	CcSEcCtD
Carvedilol—Dermatitis—Triamcinolone—systemic lupus erythematosus	3.44e-05	0.000337	CcSEcCtD
Carvedilol—Anorexia—Methotrexate—systemic lupus erythematosus	3.44e-05	0.000337	CcSEcCtD
Carvedilol—Rash—Methylprednisolone—systemic lupus erythematosus	3.43e-05	0.000337	CcSEcCtD
Carvedilol—Dermatitis—Methylprednisolone—systemic lupus erythematosus	3.43e-05	0.000337	CcSEcCtD
Carvedilol—Urticaria—Prednisone—systemic lupus erythematosus	3.43e-05	0.000336	CcSEcCtD
Carvedilol—Headache—Triamcinolone—systemic lupus erythematosus	3.42e-05	0.000335	CcSEcCtD
Carvedilol—Headache—Methylprednisolone—systemic lupus erythematosus	3.41e-05	0.000335	CcSEcCtD
Carvedilol—Abdominal pain—Prednisone—systemic lupus erythematosus	3.41e-05	0.000334	CcSEcCtD
Carvedilol—Body temperature increased—Prednisone—systemic lupus erythematosus	3.41e-05	0.000334	CcSEcCtD
Carvedilol—Diarrhoea—Betamethasone—systemic lupus erythematosus	3.39e-05	0.000332	CcSEcCtD
Carvedilol—Diarrhoea—Dexamethasone—systemic lupus erythematosus	3.39e-05	0.000332	CcSEcCtD
Carvedilol—GJA1—Dexamethasone—Triamcinolone—systemic lupus erythematosus	3.39e-05	0.0115	CbGdCrCtD
Carvedilol—GJA1—Betamethasone—Triamcinolone—systemic lupus erythematosus	3.39e-05	0.0115	CbGdCrCtD
Carvedilol—Hypotension—Methotrexate—systemic lupus erythematosus	3.37e-05	0.00033	CcSEcCtD
Carvedilol—VEGFA—Betamethasone—Hydrocortisone—systemic lupus erythematosus	3.29e-05	0.0112	CbGdCrCtD
Carvedilol—VEGFA—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	3.29e-05	0.0112	CbGdCrCtD
Carvedilol—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	3.28e-05	0.000322	CcSEcCtD
Carvedilol—Dizziness—Dexamethasone—systemic lupus erythematosus	3.28e-05	0.000321	CcSEcCtD
Carvedilol—Dizziness—Betamethasone—systemic lupus erythematosus	3.28e-05	0.000321	CcSEcCtD
Carvedilol—Insomnia—Methotrexate—systemic lupus erythematosus	3.26e-05	0.00032	CcSEcCtD
Carvedilol—Nausea—Triamcinolone—systemic lupus erythematosus	3.24e-05	0.000318	CcSEcCtD
Carvedilol—Paraesthesia—Methotrexate—systemic lupus erythematosus	3.24e-05	0.000318	CcSEcCtD
Carvedilol—Nausea—Methylprednisolone—systemic lupus erythematosus	3.24e-05	0.000317	CcSEcCtD
Carvedilol—GJA1—Dexamethasone—Prednisone—systemic lupus erythematosus	3.22e-05	0.0109	CbGdCrCtD
Carvedilol—GJA1—Betamethasone—Prednisone—systemic lupus erythematosus	3.22e-05	0.0109	CbGdCrCtD
Carvedilol—Dyspnoea—Methotrexate—systemic lupus erythematosus	3.21e-05	0.000315	CcSEcCtD
Carvedilol—Somnolence—Methotrexate—systemic lupus erythematosus	3.21e-05	0.000314	CcSEcCtD
Carvedilol—Hypersensitivity—Prednisone—systemic lupus erythematosus	3.18e-05	0.000312	CcSEcCtD
Carvedilol—Dyspepsia—Methotrexate—systemic lupus erythematosus	3.17e-05	0.000311	CcSEcCtD
Carvedilol—Vomiting—Betamethasone—systemic lupus erythematosus	3.15e-05	0.000309	CcSEcCtD
Carvedilol—Vomiting—Dexamethasone—systemic lupus erythematosus	3.15e-05	0.000309	CcSEcCtD
Carvedilol—GJA1—Betamethasone—Prednisolone—systemic lupus erythematosus	3.14e-05	0.0107	CbGdCrCtD
Carvedilol—GJA1—Dexamethasone—Prednisolone—systemic lupus erythematosus	3.14e-05	0.0107	CbGdCrCtD
Carvedilol—Decreased appetite—Methotrexate—systemic lupus erythematosus	3.13e-05	0.000307	CcSEcCtD
Carvedilol—Rash—Dexamethasone—systemic lupus erythematosus	3.12e-05	0.000306	CcSEcCtD
Carvedilol—Rash—Betamethasone—systemic lupus erythematosus	3.12e-05	0.000306	CcSEcCtD
Carvedilol—Dermatitis—Betamethasone—systemic lupus erythematosus	3.12e-05	0.000306	CcSEcCtD
Carvedilol—Dermatitis—Dexamethasone—systemic lupus erythematosus	3.12e-05	0.000306	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	3.11e-05	0.000305	CcSEcCtD
Carvedilol—Fatigue—Methotrexate—systemic lupus erythematosus	3.11e-05	0.000305	CcSEcCtD
Carvedilol—VEGFA—Betamethasone—Methylprednisolone—systemic lupus erythematosus	3.11e-05	0.0106	CbGdCrCtD
Carvedilol—VEGFA—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	3.11e-05	0.0106	CbGdCrCtD
Carvedilol—Headache—Betamethasone—systemic lupus erythematosus	3.1e-05	0.000304	CcSEcCtD
Carvedilol—Headache—Dexamethasone—systemic lupus erythematosus	3.1e-05	0.000304	CcSEcCtD
Carvedilol—Asthenia—Prednisone—systemic lupus erythematosus	3.1e-05	0.000304	CcSEcCtD
Carvedilol—Pain—Methotrexate—systemic lupus erythematosus	3.08e-05	0.000302	CcSEcCtD
Carvedilol—VEGFA—Dexamethasone—Betamethasone—systemic lupus erythematosus	3.06e-05	0.0104	CbGdCrCtD
Carvedilol—VEGFA—Betamethasone—Dexamethasone—systemic lupus erythematosus	3.06e-05	0.0104	CbGdCrCtD
Carvedilol—Pruritus—Prednisone—systemic lupus erythematosus	3.05e-05	0.000299	CcSEcCtD
Carvedilol—VEGFA—Betamethasone—Triamcinolone—systemic lupus erythematosus	2.99e-05	0.0102	CbGdCrCtD
Carvedilol—VEGFA—Dexamethasone—Triamcinolone—systemic lupus erythematosus	2.99e-05	0.0102	CbGdCrCtD
Carvedilol—Feeling abnormal—Methotrexate—systemic lupus erythematosus	2.97e-05	0.000291	CcSEcCtD
Carvedilol—Diarrhoea—Prednisone—systemic lupus erythematosus	2.95e-05	0.00029	CcSEcCtD
Carvedilol—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.95e-05	0.000289	CcSEcCtD
Carvedilol—Nausea—Dexamethasone—systemic lupus erythematosus	2.94e-05	0.000289	CcSEcCtD
Carvedilol—Nausea—Betamethasone—systemic lupus erythematosus	2.94e-05	0.000289	CcSEcCtD
Carvedilol—Urticaria—Methotrexate—systemic lupus erythematosus	2.86e-05	0.000281	CcSEcCtD
Carvedilol—Dizziness—Prednisone—systemic lupus erythematosus	2.85e-05	0.00028	CcSEcCtD
Carvedilol—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.85e-05	0.00028	CcSEcCtD
Carvedilol—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.85e-05	0.00028	CcSEcCtD
Carvedilol—VEGFA—Dexamethasone—Prednisone—systemic lupus erythematosus	2.83e-05	0.00963	CbGdCrCtD
Carvedilol—VEGFA—Betamethasone—Prednisone—systemic lupus erythematosus	2.83e-05	0.00963	CbGdCrCtD
Carvedilol—VEGFA—Dexamethasone—Prednisolone—systemic lupus erythematosus	2.77e-05	0.0094	CbGdCrCtD
Carvedilol—VEGFA—Betamethasone—Prednisolone—systemic lupus erythematosus	2.77e-05	0.0094	CbGdCrCtD
Carvedilol—Vomiting—Prednisone—systemic lupus erythematosus	2.74e-05	0.000269	CcSEcCtD
Carvedilol—Rash—Prednisone—systemic lupus erythematosus	2.72e-05	0.000267	CcSEcCtD
Carvedilol—Dermatitis—Prednisone—systemic lupus erythematosus	2.72e-05	0.000267	CcSEcCtD
Carvedilol—Headache—Prednisone—systemic lupus erythematosus	2.7e-05	0.000265	CcSEcCtD
Carvedilol—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.66e-05	0.000261	CcSEcCtD
Carvedilol—Asthenia—Methotrexate—systemic lupus erythematosus	2.59e-05	0.000254	CcSEcCtD
Carvedilol—Nausea—Prednisone—systemic lupus erythematosus	2.56e-05	0.000251	CcSEcCtD
Carvedilol—Pruritus—Methotrexate—systemic lupus erythematosus	2.55e-05	0.00025	CcSEcCtD
Carvedilol—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.47e-05	0.000242	CcSEcCtD
Carvedilol—Dizziness—Methotrexate—systemic lupus erythematosus	2.38e-05	0.000234	CcSEcCtD
Carvedilol—Vomiting—Methotrexate—systemic lupus erythematosus	2.29e-05	0.000225	CcSEcCtD
Carvedilol—Rash—Methotrexate—systemic lupus erythematosus	2.27e-05	0.000223	CcSEcCtD
Carvedilol—Dermatitis—Methotrexate—systemic lupus erythematosus	2.27e-05	0.000223	CcSEcCtD
Carvedilol—Headache—Methotrexate—systemic lupus erythematosus	2.26e-05	0.000222	CcSEcCtD
Carvedilol—Nausea—Methotrexate—systemic lupus erythematosus	2.14e-05	0.00021	CcSEcCtD
Carvedilol—ADRB1—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.62e-06	4.42e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—JUNB—systemic lupus erythematosus	3.62e-06	4.42e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL2—systemic lupus erythematosus	3.61e-06	4.4e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—C3—systemic lupus erythematosus	3.61e-06	4.4e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.6e-06	4.39e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PRL—systemic lupus erythematosus	3.59e-06	4.38e-05	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.59e-06	4.38e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—JAK1—systemic lupus erythematosus	3.55e-06	4.33e-05	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.55e-06	4.32e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.52e-06	4.3e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—JAK1—systemic lupus erythematosus	3.52e-06	4.29e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—RXRA—systemic lupus erythematosus	3.49e-06	4.25e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.48e-06	4.24e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—JAK1—systemic lupus erythematosus	3.47e-06	4.24e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.44e-06	4.2e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CCR5—systemic lupus erythematosus	3.37e-06	4.1e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—TGFB1—systemic lupus erythematosus	3.36e-06	4.1e-05	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.35e-06	4.09e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.35e-06	4.08e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.34e-06	4.07e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PRL—systemic lupus erythematosus	3.34e-06	4.07e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CCR5—systemic lupus erythematosus	3.33e-06	4.07e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.32e-06	4.04e-05	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.3e-06	4.03e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CCR5—systemic lupus erythematosus	3.29e-06	4.01e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL2—systemic lupus erythematosus	3.29e-06	4.01e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—C3—systemic lupus erythematosus	3.29e-06	4.01e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—RXRA—systemic lupus erythematosus	3.29e-06	4.01e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—JAK1—systemic lupus erythematosus	3.29e-06	4.01e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.29e-06	4.01e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL2—systemic lupus erythematosus	3.28e-06	3.99e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.28e-06	3.99e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL2—systemic lupus erythematosus	3.27e-06	3.99e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL2—systemic lupus erythematosus	3.26e-06	3.98e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—IL6—systemic lupus erythematosus	3.26e-06	3.97e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—C3—systemic lupus erythematosus	3.26e-06	3.97e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.24e-06	3.96e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—JAK1—systemic lupus erythematosus	3.24e-06	3.94e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL2—systemic lupus erythematosus	3.22e-06	3.93e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—C3—systemic lupus erythematosus	3.22e-06	3.92e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.2e-06	3.9e-05	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.18e-06	3.88e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—F2—systemic lupus erythematosus	3.17e-06	3.86e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.13e-06	3.81e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CCR5—systemic lupus erythematosus	3.11e-06	3.8e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—MMP9—systemic lupus erythematosus	3.1e-06	3.78e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—MMP9—systemic lupus erythematosus	3.09e-06	3.77e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.09e-06	3.77e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.08e-06	3.76e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.07e-06	3.74e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CCR5—systemic lupus erythematosus	3.07e-06	3.74e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.05e-06	3.72e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL2—systemic lupus erythematosus	3.05e-06	3.71e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—C3—systemic lupus erythematosus	3.04e-06	3.71e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CD80—systemic lupus erythematosus	3.04e-06	3.7e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.02e-06	3.68e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL2—systemic lupus erythematosus	3e-06	3.66e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—C3—systemic lupus erythematosus	3e-06	3.65e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.97e-06	3.63e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.97e-06	3.62e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PPARG—systemic lupus erythematosus	2.95e-06	3.6e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	2.95e-06	3.59e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—EP300—systemic lupus erythematosus	2.94e-06	3.58e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—EP300—systemic lupus erythematosus	2.93e-06	3.58e-05	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.93e-06	3.58e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—F2—systemic lupus erythematosus	2.89e-06	3.52e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	2.89e-06	3.52e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—JAK1—systemic lupus erythematosus	2.87e-06	3.5e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—F2—systemic lupus erythematosus	2.86e-06	3.49e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CCL2—systemic lupus erythematosus	2.82e-06	3.44e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—F2—systemic lupus erythematosus	2.82e-06	3.44e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.78e-06	3.39e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CD80—systemic lupus erythematosus	2.77e-06	3.37e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CD80—systemic lupus erythematosus	2.74e-06	3.34e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.74e-06	3.34e-05	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.73e-06	3.32e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CCR5—systemic lupus erythematosus	2.72e-06	3.32e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CD80—systemic lupus erythematosus	2.71e-06	3.3e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.68e-06	3.27e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—F2—systemic lupus erythematosus	2.67e-06	3.26e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.67e-06	3.26e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—JAK1—systemic lupus erythematosus	2.67e-06	3.26e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL2—systemic lupus erythematosus	2.66e-06	3.25e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—C3—systemic lupus erythematosus	2.66e-06	3.24e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—ALB—systemic lupus erythematosus	2.65e-06	3.24e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—ALB—systemic lupus erythematosus	2.65e-06	3.23e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—F2—systemic lupus erythematosus	2.63e-06	3.21e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	2.63e-06	3.2e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CCL2—systemic lupus erythematosus	2.57e-06	3.14e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TYK2—systemic lupus erythematosus	2.56e-06	3.13e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CD80—systemic lupus erythematosus	2.56e-06	3.12e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.56e-06	3.12e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CCL2—systemic lupus erythematosus	2.55e-06	3.11e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.55e-06	3.11e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—NOS3—systemic lupus erythematosus	2.54e-06	3.1e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	2.53e-06	3.09e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCR5—systemic lupus erythematosus	2.53e-06	3.08e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CD80—systemic lupus erythematosus	2.52e-06	3.07e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CCL2—systemic lupus erythematosus	2.52e-06	3.07e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—NOS3—systemic lupus erythematosus	2.52e-06	3.07e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.49e-06	3.04e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL2—systemic lupus erythematosus	2.47e-06	3.02e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	2.47e-06	3.02e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—C3—systemic lupus erythematosus	2.47e-06	3.01e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	2.45e-06	2.99e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PPARG—systemic lupus erythematosus	2.4e-06	2.92e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CCL2—systemic lupus erythematosus	2.38e-06	2.9e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CCL2—systemic lupus erythematosus	2.34e-06	2.86e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.34e-06	2.85e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TYK2—systemic lupus erythematosus	2.34e-06	2.85e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—F2—systemic lupus erythematosus	2.34e-06	2.85e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PTGS2—systemic lupus erythematosus	2.32e-06	2.83e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	2.32e-06	2.83e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TYK2—systemic lupus erythematosus	2.32e-06	2.82e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NOS3—systemic lupus erythematosus	2.29e-06	2.8e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TYK2—systemic lupus erythematosus	2.29e-06	2.79e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.28e-06	2.77e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NOS3—systemic lupus erythematosus	2.27e-06	2.77e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NOS3—systemic lupus erythematosus	2.24e-06	2.74e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CD80—systemic lupus erythematosus	2.24e-06	2.73e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PPARG—systemic lupus erythematosus	2.2e-06	2.68e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.18e-06	2.66e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—F2—systemic lupus erythematosus	2.17e-06	2.65e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TYK2—systemic lupus erythematosus	2.16e-06	2.64e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—ALB—systemic lupus erythematosus	2.16e-06	2.63e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL2—systemic lupus erythematosus	2.13e-06	2.6e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TYK2—systemic lupus erythematosus	2.13e-06	2.6e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL6—systemic lupus erythematosus	2.12e-06	2.59e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NOS3—systemic lupus erythematosus	2.12e-06	2.59e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	2.1e-06	2.56e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NOS3—systemic lupus erythematosus	2.09e-06	2.55e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CCL2—systemic lupus erythematosus	2.08e-06	2.54e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CD80—systemic lupus erythematosus	2.08e-06	2.54e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PPARG—systemic lupus erythematosus	2.08e-06	2.53e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—NOS3—systemic lupus erythematosus	2.06e-06	2.51e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MMP9—systemic lupus erythematosus	2.02e-06	2.46e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.01e-06	2.45e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.99e-06	2.42e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—ALB—systemic lupus erythematosus	1.98e-06	2.41e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.97e-06	2.4e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.94e-06	2.37e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL2—systemic lupus erythematosus	1.94e-06	2.37e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.94e-06	2.37e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.93e-06	2.36e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCL2—systemic lupus erythematosus	1.93e-06	2.36e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—EP300—systemic lupus erythematosus	1.93e-06	2.35e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—EP300—systemic lupus erythematosus	1.93e-06	2.35e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL2—systemic lupus erythematosus	1.93e-06	2.35e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL6—systemic lupus erythematosus	1.93e-06	2.35e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL6—systemic lupus erythematosus	1.92e-06	2.34e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL6—systemic lupus erythematosus	1.92e-06	2.34e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—EP300—systemic lupus erythematosus	1.91e-06	2.33e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL2—systemic lupus erythematosus	1.9e-06	2.32e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—NOS3—systemic lupus erythematosus	1.89e-06	2.31e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL6—systemic lupus erythematosus	1.89e-06	2.31e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TYK2—systemic lupus erythematosus	1.89e-06	2.31e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PTGS2—systemic lupus erythematosus	1.89e-06	2.3e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—ALB—systemic lupus erythematosus	1.87e-06	2.28e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.86e-06	2.26e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.84e-06	2.24e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.84e-06	2.24e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.83e-06	2.24e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MMP9—systemic lupus erythematosus	1.82e-06	2.22e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.82e-06	2.22e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.81e-06	2.21e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.81e-06	2.21e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MMP9—systemic lupus erythematosus	1.8e-06	2.19e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL2—systemic lupus erythematosus	1.8e-06	2.19e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.79e-06	2.19e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL6—systemic lupus erythematosus	1.79e-06	2.18e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—NOS3—systemic lupus erythematosus	1.79e-06	2.18e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL2—systemic lupus erythematosus	1.77e-06	2.16e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL6—systemic lupus erythematosus	1.76e-06	2.15e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TYK2—systemic lupus erythematosus	1.76e-06	2.14e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—EP300—systemic lupus erythematosus	1.74e-06	2.13e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PTGS2—systemic lupus erythematosus	1.73e-06	2.11e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—EP300—systemic lupus erythematosus	1.73e-06	2.11e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.72e-06	2.1e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—EP300—systemic lupus erythematosus	1.71e-06	2.08e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MMP9—systemic lupus erythematosus	1.7e-06	2.08e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.7e-06	2.07e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MMP9—systemic lupus erythematosus	1.68e-06	2.04e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.67e-06	2.04e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.66e-06	2.03e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	1.66e-06	2.02e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.65e-06	2.01e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.64e-06	2e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PTGS2—systemic lupus erythematosus	1.63e-06	1.99e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.62e-06	1.97e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.62e-06	1.97e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—EP300—systemic lupus erythematosus	1.61e-06	1.97e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.61e-06	1.96e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—EP300—systemic lupus erythematosus	1.59e-06	1.94e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL2—systemic lupus erythematosus	1.57e-06	1.92e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—EP300—systemic lupus erythematosus	1.57e-06	1.91e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.57e-06	1.91e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	1.56e-06	1.9e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	1.55e-06	1.89e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.53e-06	1.86e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.52e-06	1.85e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.51e-06	1.84e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.5e-06	1.83e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.49e-06	1.82e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—ALB—systemic lupus erythematosus	1.49e-06	1.82e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.49e-06	1.82e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.48e-06	1.81e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.48e-06	1.81e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL2—systemic lupus erythematosus	1.46e-06	1.78e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.45e-06	1.77e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—EP300—systemic lupus erythematosus	1.44e-06	1.76e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	1.43e-06	1.74e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—EP300—systemic lupus erythematosus	1.41e-06	1.72e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	1.4e-06	1.71e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.4e-06	1.71e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	1.39e-06	1.7e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.38e-06	1.69e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.38e-06	1.68e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.38e-06	1.68e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—EP300—systemic lupus erythematosus	1.36e-06	1.66e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	1.34e-06	1.64e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.34e-06	1.63e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	1.33e-06	1.62e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	1.32e-06	1.61e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—EP300—systemic lupus erythematosus	1.31e-06	1.6e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	1.3e-06	1.59e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL6—systemic lupus erythematosus	1.25e-06	1.53e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.24e-06	1.51e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	1.23e-06	1.5e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.23e-06	1.5e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	1.22e-06	1.49e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	1.19e-06	1.45e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL6—systemic lupus erythematosus	1.14e-06	1.39e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.14e-06	1.39e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	1.14e-06	1.39e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL6—systemic lupus erythematosus	1.13e-06	1.38e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL6—systemic lupus erythematosus	1.12e-06	1.36e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.08e-06	1.32e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL6—systemic lupus erythematosus	1.06e-06	1.29e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	1.04e-06	1.27e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL6—systemic lupus erythematosus	1.04e-06	1.27e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	1.02e-06	1.25e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.02e-06	1.25e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	1.01e-06	1.24e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL6—systemic lupus erythematosus	9.25e-07	1.13e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	9.19e-07	1.12e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	8.79e-07	1.07e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	8.66e-07	1.06e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL6—systemic lupus erythematosus	8.59e-07	1.05e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	8.04e-07	9.8e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	6.68e-07	8.15e-06	CbGpPWpGaD
